Renato Delascio Lopes, MD, PhD

Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 2400 Pratt St, Durham, NC 27710
Phone (919) 668-8596
Email address renato.lopes@duke.edu

Atrial Fibrillation
Antithrombotic Therapy in patients with Acute Coronary Syndromes
Elderly patients with Heart Disease
Biomarkers in Acute Coronary Syndromes and Atrial Fibrillation
Thrombosis and Anticoagulation and novel antithrombotic agents
Metabolomics in Cardiovascular Medicine

Education and Training

  • M.H.S., Duke University School of Medicine, 2009
  • Ph.D., Paulista Medical School, University of Sao Paulo (Brazil), 2006
  • M.D., University of Santo Amaro (Brazil), 2001

Publications

Carnicelli, Anthony P., Hwanhee Hong, Robert P. Giugliano, Stuart J. Connolly, John Eikelboom, Manesh R. Patel, Lars Wallentin, et al. “Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) Investigators.” Am Heart J 233 (March 2021): 48–58. https://doi.org/10.1016/j.ahj.2020.12.002.

PMID
33296688
Full Text

Chaitman, Bernard R., Karen P. Alexander, Derek D. Cyr, Jeffrey S. Berger, Harmony R. Reynolds, Sripal Bangalore, William E. Boden, et al. “Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.” Circulation 143, no. 8 (February 23, 2021): 790–804. https://doi.org/10.1161/CIRCULATIONAHA.120.047987.

PMID
33267610
Full Text

Angiolillo, Dominick J., Deepak L. Bhatt, Christopher P. Cannon, John W. Eikelboom, C Michael Gibson, Shaun G. Goodman, Christopher B. Granger, et al. “Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.” Circulation 143, no. 6 (February 9, 2021): 583–96. https://doi.org/10.1161/CIRCULATIONAHA.120.050438.

PMID
33555916
Full Text

Aflaki, Mona, Alexandria Flannery, João Pedro Ferreira, Matthew Pellan Cheng, Nadine Kronfli, Ariane Marelli, Faiez Zannad, et al. “Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.” Trials 22, no. 1 (February 5, 2021): 115. https://doi.org/10.1186/s13063-021-05080-4.

PMID
33546734
Full Text

Lopes, Renato D., Amit N. Vora, and John H. Alexander. “Antithrombotic Strategies in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention-Reply.” Jama Cardiol 6, no. 2 (February 1, 2021): 241. https://doi.org/10.1001/jamacardio.2020.4759.

PMID
33026416
Full Text

Varshney, Anubodh S., David E. Wang, Ankeet S. Bhatt, Alexander Blood, Musa A. Sharkawi, Hasan K. Siddiqi, Muthiah Vaduganathan, et al. “Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis.” American Heart Journal 232 (February 2021): 105–15. https://doi.org/10.1016/j.ahj.2020.10.065.

PMID
33121978
Full Text

Salah, Husam M., Subhi J. Al’Aref, Muhammad Shahzeb Khan, Malek Al-Hawwas, Srikanth Vallurupalli, Jawahar L. Mehta, J Paul Mounsey, et al. “Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials.” Am Heart J 232 (February 2021): 10–22. https://doi.org/10.1016/j.ahj.2020.10.064.

PMID
33214130
Full Text

Benjamin, Emelia J., Alan S. Go, Patrice Desvigne-Nickens, Christopher D. Anderson, Barbara Casadei, Lin Y. Chen, Harry J. G. M. Crijns, et al. “Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop.” Circulation 143, no. 4 (January 26, 2021): 372–88. https://doi.org/10.1161/CIRCULATIONAHA.120.047633.

PMID
33493033
Full Text

Veiga, Viviane C., João A. G. G. Prats, Danielle L. C. Farias, Regis G. Rosa, Leticia K. Dourado, Fernando G. Zampieri, Flávia R. Machado, et al. “Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial.” Bmj 372 (January 20, 2021): n84. https://doi.org/10.1136/bmj.n84.

PMID
33472855
Full Text

Nelson, Adam J., Maddalena Ardissino, Kevin Haynes, Sonali Shambhu, Zubin J. Eapen, Darren K. McGuire, Anthony Carnicelli, et al. “Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease.” J Am Heart Assoc 10, no. 2 (January 19, 2021): e016835. https://doi.org/10.1161/JAHA.120.016835.

PMID
33432843
Full Text

Pages